CRI Worldwide has completed its acquisition of Lifetree Clinical Research. The acquisition combines CRI’s position in psychiatry and patient population studies with Lifetree’s expertise in pain management and human abuse liability, as well as performing complex studies in early-stage clinical research. The acquisition expands CRI’s clinical pharmacology capacity to more than 120 beds. The combined organization will provide a broad range of psychiatry and neurology research products and servic...